Department of Urology, Mayo Clinic, 200 1st St. SW, Rochester, MN, 55905, USA.
Department of Health Sciences Research, Rochester, MN, USA.
World J Urol. 2017 Dec;35(12):1879-1884. doi: 10.1007/s00345-017-2087-4. Epub 2017 Sep 14.
To evaluate perioperative and oncologic outcomes of patients undergoing radical cystectomy (RC) for recurrence of urothelial carcinoma (UC) after prior partial cystectomy (PC), and to compare these outcomes to patients undergoing primary RC.
Patients who underwent RC for recurrence of UC after prior PC were matched 1:3 to patients undergoing primary RC based on age, pathologic stage, and decade of surgery. Perioperative and oncologic outcomes were compared using Wilcoxon sign-rank test, McNemars test, the Kaplan-Meier method, and Cox proportional hazards regression analyses.
Overall, the cohorts were well matched on clinical and pathological characteristics. No difference was noted in operative time (median 322 versus 303 min; p = 0.41), estimated blood loss (median 800 versus 700 cc, p = 0.10) or length of stay (median 9 versus 10 days; p = 0.09). Similarly, there were no differences in minor (51.7 versus 44.3%; p = 0.32) or major (10.3 versus 12.6%; p = 0.66) perioperative complications. Median follow-up after RC was 5.0 years (IQR 1.5, 13.1 years). Notably, CSS was significantly worse for patients who underwent RC after PC (10 year-46.8 versus 65.9%; p = 0.03). On multivariable analysis, prior PC remained independently associated with an increased risk of bladder cancer death (HR 2.28; 95% CI 1.17, 4.42).
RC after PC is feasible, without significantly adverse perioperative outcomes compared to patients undergoing primary RC. However, the risk of death from bladder cancer may be higher, suggesting the need for careful patient counseling prior to PC and the consideration of such patients for adjuvant therapy after RC.
评估先前接受过部分膀胱切除术(PC)的患者因尿路上皮癌(UC)复发而行根治性膀胱切除术(RC)的围手术期和肿瘤学结果,并将这些结果与初次接受 RC 的患者进行比较。
根据年龄、病理分期和手术年代,将先前接受 PC 后因 UC 复发而行 RC 的患者与初次接受 RC 的患者进行 1:3 匹配。使用 Wilcoxon 符号秩检验、McNemar 检验、Kaplan-Meier 方法和 Cox 比例风险回归分析比较围手术期和肿瘤学结果。
总体而言,两组在临床和病理特征上匹配良好。手术时间(中位数 322 与 303 分钟;p=0.41)、估计失血量(中位数 800 与 700cc;p=0.10)或住院时间(中位数 9 与 10 天;p=0.09)无差异。同样,轻微(51.7%与 44.3%;p=0.32)或主要(10.3%与 12.6%;p=0.66)围手术期并发症也无差异。RC 后中位随访时间为 5.0 年(IQR 1.5,13.1 年)。值得注意的是,PC 后行 RC 的患者 CSS 明显较差(10 年-46.8%与 65.9%;p=0.03)。多变量分析显示,先前的 PC 仍然与膀胱癌死亡风险增加独立相关(HR 2.28;95%CI 1.17,4.42)。
PC 后行 RC 是可行的,与初次接受 RC 的患者相比,围手术期结果没有明显的不良影响。然而,膀胱癌死亡的风险可能更高,这表明在 PC 前需要对患者进行仔细的咨询,并考虑对 PC 后患者进行辅助治疗。